4D Molecular Therapeutics (FDMT) EBT Margin Growth (1y) (2021 - 2026)
4D Molecular Therapeutics (FDMT) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | 4D Molecular Therapeutics | 706.51 Mn | 315.62 Mn | - | 35.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 505.50 Mn |
| Sep 30, 2025 | 250.30 Mn |
| Jun 30, 2025 | 30.98 Mn |
| Mar 31, 2025 | -21.36 Mn |
| Dec 31, 2024 | -522.91 Mn |
| Sep 30, 2024 | -259.83 Mn |
| Jun 30, 2024 | -88.75 Mn |
| Mar 31, 2024 | -12.30 Mn |
| Dec 31, 2023 | 17.65 Mn |
| Sep 30, 2023 | 931,985.00 |
| Jun 30, 2023 | -32,662.00 |
| Mar 31, 2023 | -1.38 Mn |
| Dec 31, 2022 | 2.61 Mn |
| Sep 30, 2022 | -598,415.00 |
| Jun 30, 2022 | -2.11 Mn |
| Mar 31, 2022 | -56,957.00 |
| Dec 31, 2021 | -2.77 Mn |
| Sep 30, 2021 | -337,438.00 |
| Jun 30, 2021 | 35,741.00 |